Related Experiment Video
Updated: Apr 7, 2026

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
Published on: July 25, 2022
I53-50: Engineered icosahedral protein cage for modular vaccine nanoplatform
Ke Liang1, Shuang Wu1, Sihang Dong1
1Anhui Province Key Laboratory of Immunology in Chronic Diseases, Laboratory Medicine Experimental Center, Laboratory Medicine College, Bengbu Medical University, Bengbu 233030, P. R. China.
Abstract:
I53-50 is a computationally designed, self-assembling protein nanoparticle (NP) that forms a stable icosahedral structure composed of 120 protein subunits coordinated through precise interfacial interactions. Through unique intelligent regulation, I53-50 exhibits sensitivity to environmental signals and display multimodal "nano-smart" properties. I53-50 has a variety of modifiable surface-active sites, which facilitates precise chemical modification, gene fusion, tag coupling, and other functionalizations, thereby promoting effective lymphatic uptake and optimizing the immune response. I53-50 NPs show great potential in vaccine development, drug delivery, and biomaterials, representing a model fusion of computational biology and nanomedicine and offering a versatile tool for precision medicine.

